| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D M Taylor, D Duncan-McConnel. Refractory schizophrenia and atypical antipsychotics. Journal of psychopharmacology (Oxford, England). vol 14. issue 4. 2001-05-31. PMID:11198061. |
refractory schizophrenia and atypical antipsychotics. |
2001-05-31 |
2023-08-12 |
Not clear |
| D Taylo. Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302890. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| R Kerwi. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302914. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| S Le. Atypical antipsychotics in the treatment of schizophrenia. "Informed relationship between doctor and patient" does not exist in many parts of the world. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302915. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| C Adams, L Dugga. Atypical antipsychotics in the treatment of schizophrenia. Paper corrupts concept of evidence based medicine. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302916. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| R Rowsell, C Link, J Donoghu. Atypical antipsychotics in the treatment of schizophrenia. Validity of dropout rates as proxy measure of tolerability is unknown. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302917. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| I Anderso. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302919. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| R Duggins, D Rhinds, W Hal. Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302921. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| C Prior, J Clements, M Rowet. Atypical antipsychotics in the treatment of schizophrenia. Users' experiences of treatments must be considered. BMJ (Clinical research ed.). vol 322. issue 7291. 2001-05-17. PMID:11302924. |
atypical antipsychotics in the treatment of schizophrenia. |
2001-05-17 |
2023-08-12 |
Not clear |
| S Kapur, G Remingto. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annual review of medicine. vol 52. 2001-04-26. PMID:11160792. |
atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| T Wetterlin. Bodyweight gain with atypical antipsychotics. A comparative review. Drug safety. vol 24. issue 1. 2001-04-19. PMID:11219487. |
the atypical antipsychotics have been shown to have superior efficacy compared with typical antipsychotics such as haloperidol, particularly in the treatment of negative symptoms of schizophrenia. |
2001-04-19 |
2023-08-12 |
Not clear |
| D A Revick. The new atypical antipsychotics: a review of pharmacoeconomic studies. Expert opinion on pharmacotherapy. vol 1. issue 2. 2001-04-05. PMID:11249546. |
the pharmacoeconomic evaluation of atypical antipsychotics for the treatment of schizophrenia involves documentation of clinical effectiveness, quality of life and medical cost outcomes. |
2001-04-05 |
2023-08-12 |
Not clear |
| A Khullar, P Chue, P Tibb. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS. Journal of psychiatry & neuroscience : JPN. vol 26. issue 1. 2001-03-15. PMID:11212595. |
the atypical antipsychotics have advanced the treatment of schizophrenia and have proved to be effective agents in treating other disorders with or without psychotic features. |
2001-03-15 |
2023-08-12 |
Not clear |
| S Murawie. [Neuroleptics, atypical antipsychotics and "awakening"]. Psychiatria polska. vol 34. issue 5. 2001-02-22. PMID:11202016. |
they deal with new problems and challenges connected with treatment of patients with acute and chronic schizophrenia with atypical antipsychotics. |
2001-02-22 |
2023-08-12 |
Not clear |
| J Geddes, N Freemantle, P Harrison, P Bebbingto. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (Clinical research ed.). vol 321. issue 7273. 2001-02-15. PMID:11099280. |
atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. |
2001-02-15 |
2023-08-12 |
Not clear |
| J Geddes, N Freemantle, P Harrison, P Bebbingto. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (Clinical research ed.). vol 321. issue 7273. 2001-02-15. PMID:11099280. |
to develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia. |
2001-02-15 |
2023-08-12 |
Not clear |
| A Jatzko, S Ries, A Schreiner, D F Brau. [Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example]. Der Nervenarzt. vol 71. issue 11. 2001-02-02. PMID:11103369. |
with the advent of atypical antipsychotics, quality of life for patients with schizophrenia has improved significantly. |
2001-02-02 |
2023-08-12 |
Not clear |
| K K Jai. An assessment of iloperidone for the treatment of schizophrenia. Expert opinion on investigational drugs. vol 9. issue 12. 2001-01-08. PMID:11093363. |
current trends in the treatment of schizophrenia indicate that some atypical antipsychotics are being recommended as first-line therapy. |
2001-01-08 |
2023-08-12 |
mouse |
| A Portier, Y Sarfat. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics]. L'Encephale. vol 26. issue 4. 2001-01-02. PMID:11064844. |
we examine the value of first-line treatment of schizophrenia with atypical antipsychotics as of the first acute episodes of acute delirium in the light of current data in the literature. |
2001-01-02 |
2023-08-12 |
Not clear |
| S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. |
the introduction of atypical antipsychotics has triggered a reevaluation of treatment strategies in schizophrenia. |
2000-08-24 |
2023-08-12 |
Not clear |